References
- Holick MF. The statin D-lemme. Dermatoendocrinol 2012; 4:10 - 1
- Glossman HH, Blumthaler M. Does Rosuvastatin increase serum levels of 25-hydroxy-vitamin D?. Dermatoendocrinol 2012; 4:2 - 7
- Yavuz B, Ertugrul DT. Statins and vitamin D: A hot topic that will be discussed for a long time. Dermatoendocrinol 2012; 4:8 - 9
- Grant WB. On the roles of solar ultraviolet irradiance and smoking on the diagnosis of second cancers after diagnosis of melanoma. Dermatoendocrinol 2012; 12 - 17
- Berwick M. How do solar ultraviolet irradiance and smoking impact the diagnosis of second cancers after diagnosis of melanoma? No answer yet. Dermatoendocrinol 2012; 4:18 - 9
- Melnik B. Dietary intervention in acne: Attenuation of increased mTORC1 signaling promoted by Western diet. Dermatoendocrinol 2012; 4:20 - 32
- den Engelsen C, van den Donk M, Gorter KJ, Salomé PL, Rutten GE. Advanced glycation end products measured by skin autofluorescence in a population with central obesity. Dermatoendocrinol 2012; 4:33 - 43
- Rajah J, Haq A, Pettifor JM. Vitamin D and calcium status in urban children attending an ambulatory clinic service in the United Arab Emirates. Dermatoendocrinol 2012; 4:44 - 8
- Reichrath S, Reichrath J. No evidence for induction of key components of the Notch signaling pathway (Notch-1, Jagged-1) by treatment with UV-B, 1,25(OH)2D3, and/or epigenetic drugs (TSA, 5-Aza) in human keratinocytes in vitro. Dermatoendocrinol 2012; 4:49 - 57
- Rodriguez-Martin M, Sáez M, de Paz NM, Ferrer PC, Eliche MP, Rodríguez-Martín B, et al. When are laboratory tests indicated in patients with vitiligo?. Dermatoendocrinol 2012; 4:58 - 62
- Haag M, Hamann T, Kulle AE, Riepe FG, Blatt T, Wenck H, et al. Age and skin site related differences in steroid metabolism in male skin point to a key role of sebocytes in cutaneous hormone metabolism. Dermatoendocrinol 2012; 4:63 - 9
- Lutz G. Hair loss and hyperprolactinemia in women. Dermatoendocrinol 2012; 4:70 - 6
- Ringe JD, Kipshoven C. Vitamin D-insufficiency: An estimate of the situation in Germany. Dermatoendocrinol 2012; 4:77 - 85